STATE STREET CORP - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 71 filers reported holding ALBIREO PHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$15,045,488
+121.7%
696,228
+98.6%
0.00%
Q3 2022$6,787,000
-76.0%
350,544
-75.4%
0.00%
-100.0%
Q2 2022$28,287,000
+4.4%
1,424,343
+56.7%
0.00%
+100.0%
Q1 2022$27,107,000
+17.2%
908,728
-8.5%
0.00%0.0%
Q4 2021$23,123,000
-29.7%
992,832
-5.9%
0.00%
-50.0%
Q3 2021$32,913,000
+10.7%
1,054,911
+24.8%
0.00%0.0%
Q2 2021$29,744,000
-15.8%
845,483
-15.6%
0.00%0.0%
Q1 2021$35,309,000
+20.4%
1,001,660
+28.1%
0.00%0.0%
Q4 2020$29,324,000
+292.9%
781,765
+249.6%
0.00%
+100.0%
Q3 2020$7,463,000
+24.3%
223,648
-1.3%
0.00%
Q2 2020$6,003,000
+66.8%
226,624
+3.1%
0.00%
Q1 2020$3,600,000
-26.9%
219,915
+13.6%
0.00%
Q4 2019$4,922,000
+26.4%
193,626
-0.6%
0.00%
Q3 2019$3,895,000
-31.5%
194,752
+10.4%
0.00%
Q2 2019$5,688,000
+24.3%
176,412
+24.1%
0.00%
Q1 2019$4,577,000
+34.1%
142,108
+2.1%
0.00%
Q4 2018$3,414,000
-29.1%
139,167
-4.8%
0.00%
Q3 2018$4,817,000
-3.4%
146,180
+4.2%
0.00%
Q2 2018$4,984,000140,3120.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
Prosight Management, LP 491,244$9,510,0005.10%
Decheng Capital Management III (Cayman), LLC 623,342$12,068,0004.38%
TANG CAPITAL MANAGEMENT LLC 1,099,516$21,287,0002.61%
Privium Fund Management B.V. 300,252$5,624,0002.04%
Birchview Capital, LP 117,000$2,265,0001.60%
Perceptive Advisors 2,360,139$45,692,0001.33%
Chicago Capital, LLC 1,119,774$21,679,0001.25%
Endurant Capital Management LP 172,621$3,342,0001.09%
Deep Track Capital, LP 1,110,624$21,502,0000.98%
SPHERA FUNDS MANAGEMENT LTD. 359,000$6,950,0000.96%
View complete list of ALBIREO PHARMA INC shareholders